跳至主要内容
临床试验/NCT02839551
NCT02839551已完成不适用

Optimal Step Doses for Drug Provocation Tests to Prove Beta-lactam Hypersensitivity

University Hospital, Montpellier2 个研究点 分布在 1 个国家目标入组 1,252 人开始时间: 2016年5月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,252
试验地点
2
主要终点
Assessment of the new simplified drug provocation test

研究概览

简要总结

Drug provocation tests (DPT) are widely in case of suspicion of drug hypersensitivity (and in the absence of contraindications), but there are no standardized protocols and most groups use hypothesis (clinically-driven) protocols.

investigators used 20 year experience in drug hypersensitivity to analyse retrospectively 171 patients (accounting for 182 positive DPT to beta-lactams). Using survival analysis, they identified optimal doses to include in a data-driven protocol. This data-driven protocol will be applied to new prospective patients, to test its safety and benefits (gain in time, hospital and patient benefits).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patients with positive Drug Provocation Test (DPT) to beta-lactams

排除标准

  • contra-indications to DPT
  • refusal of participation
  • vulnerable patients according to French regulation

结局指标

主要结局

Assessment of the new simplified drug provocation test

时间窗: up to 1 hour

Assessment of the non inferiority of the new drug provocation test compared to the present drug provocation test

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验